下水凝用于春季介导的肠道延长
Fereshteh Salimi-Jazi1, Narelli de Paiva Narciso2, Gillian Fell3
1Division of Pediatric Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, California, USA.
Journal of biomedical materials research. Part A
|September 22, 2025
概括
工程水凝允许内镜弹放置以延长肠道. 这种以凝为主,弹为媒介的分心肠生成显示了扩大肠表皮的有希望的结果.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 胃肠病学 胃肠病学
背景情况:
- 春季介导的分心肠生成是一种肠道延长的技术.
- 目前的方法需要外部合以接,以限制弹,增加患病率.
- 通过内镜装置插入来最大限度地减少侵入性是关键目标.
研究的目的:
- 调查工程水凝的使用,以便在肠道段内暂时封闭弹.
- 评估以凝为主,弹介导的分心肠生成,以延长肠道的可行性.
- 评估水凝封闭弹对肠段扩张和组织学的影响.
主要方法:
- 开发了工程化水凝 (单独使用氨酸或与弹性蛋白类似的蛋白质).
- 水凝被注射到猪阴的粘膜下,以限制一个压缩的尼醇弹.
- 在7天后分析了肠道细分,以检测延长和组织学变化.
主要成果:
- 无论是HA和HELP的水凝都有效地限制了弹,导致肠道段扩张.
- 在HA组显示了132%的延长,而在HELP组显示了188%的延长.
- 组织学分析显示,密室宽度增加,密室密度降低,表明上皮细胞扩张.
结论:
- 工程水凝为弹介导的分心肠生成提供了有效的临时弹限制.
- 凝激活的内镜弹放置将与当前技术相关的发病率降至最低.
- 来自弹的机械刺激促进密室裂变和肠上皮质扩张,支持其临床可行性.
相关概念视频
01:23Renewal of Intestinal Stem Cells
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...